Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2037

1.

The expression analysis of NGAL and NGALR in clear cell renal cell carcinoma.

Liu F, Li N, Yang W, Wang R, Yu J, Wang X.

Gene. 2018 Nov 15;676:269-278. doi: 10.1016/j.gene.2018.08.060. Epub 2018 Aug 20.

PMID:
30138675
2.

Mitigation of cell apoptosis induced by ochratoxin A (OTA) is possibly through organic cation transport 2 (OCT2) knockout.

Qi X, Zhu L, Yang B, Luo H, Xu W, He X, Huang K.

Food Chem Toxicol. 2018 Aug 16;121:15-23. doi: 10.1016/j.fct.2018.08.026. [Epub ahead of print]

PMID:
30120945
3.

Importance of OCT2 and MATE1 for the Cimetidine-Metformin Interaction: Insights from Investigations of Polarized Transport in Single- And Double-Transfected MDCK Cells with a Focus on Perpetrator Disposition.

Müller F, Weitz D, Mertsch K, König J, Fromm MF.

Mol Pharm. 2018 Aug 6;15(8):3425-3433. doi: 10.1021/acs.molpharmaceut.8b00416. Epub 2018 Jul 19.

PMID:
29975542
4.

Interactions of pesticides with membrane drug transporters: implications for toxicokinetics and toxicity.

Chedik L, Bruyere A, Bacle A, Potin S, Le Vée M, Fardel O.

Expert Opin Drug Metab Toxicol. 2018 Jul;14(7):739-752. doi: 10.1080/17425255.2018.1487398. Epub 2018 Jun 20. Review.

PMID:
29886753
5.

Verinurad combined with febuxostat in Japanese adults with gout or asymptomatic hyperuricaemia: a phase 2a, open-label study.

Shiramoto M, Liu S, Shen Z, Yan X, Yamamoto A, Gillen M, Ito Y, Hall J.

Rheumatology (Oxford). 2018 Sep 1;57(9):1602-1610. doi: 10.1093/rheumatology/key100.

6.

Recent advances in drug and nutrient transport across the blood-retinal barrier.

Kubo Y, Akanuma SI, Hosoya KI.

Expert Opin Drug Metab Toxicol. 2018 May;14(5):513-531. doi: 10.1080/17425255.2018.1472764. Epub 2018 May 10. Review.

PMID:
29719158
7.

Blood-to-Retina Transport of Fluorescence-Labeled Verapamil at the Blood-Retinal Barrier.

Kubo Y, Nakazawa A, Akanuma SI, Hosoya KI.

Pharm Res. 2018 Mar 12;35(5):93. doi: 10.1007/s11095-018-2384-7.

PMID:
29532174
8.

URAT1 and GLUT9 mutations in Spanish patients with renal hypouricemia.

Claverie-Martin F, Trujillo-Suarez J, Gonzalez-Acosta H, Aparicio C, Justa Roldan ML, Stiburkova B, Ichida K, Martín-Gomez MA, Herrero Goñi M, Carrasco Hidalgo-Barquero M, Iñigo V, Enriquez R, Cordoba-Lanus E, Garcia-Nieto VM; RenalTube Group.

Clin Chim Acta. 2018 Jun;481:83-89. doi: 10.1016/j.cca.2018.02.030. Epub 2018 Feb 24.

PMID:
29486147
9.

Houttuynia cordata extract increased systemic exposure and liver concentrations of metformin through OCTs and MATEs in rats.

You BH, Chin YW, Kim H, Choi HS, Choi YH.

Phytother Res. 2018 Jun;32(6):1004-1013. doi: 10.1002/ptr.6036. Epub 2018 Feb 26.

PMID:
29480578
10.

Integrated analysis of gene expression signatures associated with colon cancer from three datasets.

Gao P, He M, Zhang C, Geng C.

Gene. 2018 May 15;654:95-102. doi: 10.1016/j.gene.2018.02.007. Epub 2018 Feb 3.

PMID:
29408621
11.

Systematic Structure-Activity Relationship (SAR) Exploration of Diarylmethane Backbone and Discovery of A Highly Potent Novel Uric Acid Transporter 1 (URAT1) Inhibitor.

Cai W, Wu J, Liu W, Xie Y, Liu Y, Zhang S, Xu W, Tang L, Wang J, Zhao G.

Molecules. 2018 Jan 27;23(2). pii: E252. doi: 10.3390/molecules23020252.

12.

Associations between the SLC22A12 gene and gout susceptibility: a meta-analysis.

Zou Y, Du J, Zhu Y, Xie X, Chen J, Ling G.

Clin Exp Rheumatol. 2018 May-Jun;36(3):442-447. Epub 2018 Jan 15.

PMID:
29352852
13.

The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury.

Ferrigno A, Di Pasqua LG, Berardo C, Siciliano V, Rizzo V, Adorini L, Richelmi P, Vairetti M.

PLoS One. 2018 Jan 18;13(1):e0191430. doi: 10.1371/journal.pone.0191430. eCollection 2018.

14.

A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: An open-label, parallel group, randomized clinical study.

Chung H, Oh J, Yoon SH, Yu KS, Cho JY, Chung JY.

PLoS One. 2018 Jan 17;13(1):e0191258. doi: 10.1371/journal.pone.0191258. eCollection 2018.

15.

Lesinurad/Allopurinol (Duzallo) for Gout-Associated Hyperuricemia.

[No authors listed]

JAMA. 2018 Jan 9;319(2):188-189. doi: 10.1001/jama.2017.20189. No abstract available.

PMID:
29318274
16.

Salt stress affects global protein expression profiles of extracellular membrane-derived vesicles of Listeria monocytogenes.

Lee T, Jun SH, Choi CW, Kim SI, Lee JC, Shin JH.

Microb Pathog. 2018 Feb;115:272-279. doi: 10.1016/j.micpath.2017.12.071. Epub 2017 Dec 30.

PMID:
29294369
17.

Integration-free induced pluripotent stem cells derived from a patient with autosomal recessive Alport syndrome (ARAS).

Kuebler B, Aran B, Miquel-Serra L, Muñoz Y, Ars E, Bullich G, Furlano M, Torra R, Marti M, Veiga A, Raya A.

Stem Cell Res. 2017 Dec;25:1-5. doi: 10.1016/j.scr.2017.08.021. Epub 2017 Sep 14.

18.

Effect and mechanism of dioscin from Dioscorea spongiosa on uric acid excretion in animal model of hyperuricemia.

Zhang Y, Jin L, Liu J, Wang W, Yu H, Li J, Chen Q, Wang T.

J Ethnopharmacol. 2018 Mar 25;214:29-36. doi: 10.1016/j.jep.2017.12.004. Epub 2017 Dec 9.

PMID:
29233733
19.

Variants of ALPK1 with ABCG2, SLC2A9, and SLC22A12 increased the positive predictive value for gout.

Tu HP, Min-Shan Ko A, Lee SS, Lee CP, Kuo TM, Huang CM, Ko YC.

J Hum Genet. 2018 Jan;63(1):63-70. doi: 10.1038/s10038-017-0368-9. Epub 2017 Nov 8.

PMID:
29215084
20.

Characterization of an L-Carnitine Transport System in Murine Photoreceptor Cell Line.

Ohno Y, Otsuka Y, Nohara M, Furihata T, Kuse Y, Itoh Y, Hara H, Anzai N.

Biol Pharm Bull. 2017;40(12):2110-2116. doi: 10.1248/bpb.b17-00461.

Supplemental Content

Loading ...
Support Center